Scranton Richard 4
4 · Pacira Pharmaceuticals, Inc. · Filed Jun 15, 2018
Insider Transaction Report
Form 4
Scranton Richard
Chief Scientific Officer
Transactions
- Award
Common Stock
2018-06-13+7,875→ 20,101 total - Award
Stock Option (Right to Buy)
2018-06-13+47,250→ 47,250 totalExercise: $38.35Exp: 2028-06-13→ Common Stock (47,250 underlying)
Footnotes (2)
- [F1]Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2019, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.
- [F2]The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.